866-997-4948(US-Canada Toll Free)

Cell Harvesting Market

Published By :

BCC Research

Published Date : May 2019

Category :

Biotechnology

No. of Pages : 148 Pages

"Summary

Stem cells are unspecialized cells that have the ability to divide indefinitely and produce specialized cells. The appropriate physiological and experimental conditions provided to the unspecialized cells give rise to certain specialized cells, including nerve cells, heart muscle cells and blood cells. Stem cells can divide and renew themselves over long periods of time. These cells are extensively found in multicellular organisms, wherein mammals, there are two types of stem cells embryonic stem cells and adult stemcells. Embryonic stem cells are derived from a human embryo four or five days old that is in the blastocyst phase of development. Adult stem cells grow after the development of the embryo and are found in tissues such as bone marrow, brain, blood vessels, blood, skin, skeletal muscles and liver. Stemcell culture is the process of harvesting the exosomes and molecules released by the stem cells for the development of therapeutics
for chronic diseases such as cancer and diabetes. The process is widely used in biomedical applications such as therapy, diagnosis and biological drug production. The global cell harvesting market is likely to witness a growth rate of REDACTED during the forecast period of 2018-2023.The value of global cell harvesting market was REDACTED in 2017 and is projected to reach REDACTED by 2023. Market growth is attributed to factors such as increasing R&D spending in cell-based research,the introduction of 3D cell culture technology, increasing government funding, and the growing prevalence of chronic diseases such as cancer and diabetes.

The growing incidence and prevalence of cancer is seen as one of the major factors contributing to the growth of the global cell harvesting market. According to the World Health Organization (WHO), cancer is the second-leading cause of mortality globally and was responsible for an estimated 9.6 million deaths in 2018. Therefore, there is an increasing need for effective cancer treatment solutions globally. Cell harvesting is the preferred method used in cancer cell-related studies including cancer cell databases (cancer cell lines), and other analyses and drug discovery in a microenvironment. The rising prevalence of such chronic diseases has led governments to provide R&D funding to research institutes and biotechnology companies to develop advanced therapeutics. Various 3D cell culture technologies have been developed by researchers and biotechnology companies such as Lonza Group and Thermo Fischer Scientific for research applications such as cancer drug discovery. The application of cell culture in cancer research is leading to more predictive models for research, drug discovery and regenerative medicine applications.

Platelet-rich plasma (PRP) therapy, a new biotechnology solution that has a heightened interest among researchers in tissue engineering and cell-based therapies, has various applications in the treatment of tissue healing in tendinopathy, osteoarthritis and muscle injury. It has been conventionally employed in orthopedics, maxillofacial surgery, periodontal therapy and sports medicines. PRP therapy can be used in the treatment of fat grafting, acne scars, and hair regrowth.

Major factors driving market growth include increasing healthcare costs and the high rate of adoption for modern medicines in emerging economies such as China and India. It has been estimated that India will witness a CAGR of REDACTED in the cell harvesting market during the forecast period. The active participation of foreign pharmaceutical companies has tapped the Indian healthcare sector with a series of partnerships and mergers and acquisitions, which in turn is positively impacting the growth of the market in this region. Consistent development and clinical trials for stem cell therapies, plus contribution from the government and private sectors through investments and cohesive reimbursement policies in the development of cancer biomarkers, is further fueling market growth. InSweden, a research team at Lund University has developed a device to collect fluid and harvest stem mesenchymal stem cells (MSCs). The device is developed with 3D-printed bio-inert plastics which, when used by doctors, can result in the safe extraction of fluids (medical waste) from the patients body. The liquid is then passed through a gauze filter for purifying thoroughly and MSCs are separated from the fluid by centrifugation and are grown in culture."

"Report Scope:

The scope of the report encompasses the major types of cell harvesting that have been used and the cell harvesting technologies that are being developed by industry, government agencies and nonprofits. It analyzes current market status, examines drivers on future markets and presents forecasts of growth over the next five years.

The report provides a summary of the market, including a market snapshot and profiles of key players in the cell harvesting market. It provides an exhaustive segmentation analysis of the market with in-depth information about each segment. The overview section of the report provides a description of market trends and market dynamics, including drivers, restraints and opportunities. it provides information about market developments and future trends that can be useful for organizations, including wholesalers and exporters. It provides market positionings of key players using yardsticks of revenue, product portfolio, and recent activities. It further includes strategies adopted by emerging market players with strategic recommendations for new market entrants. Readers will also find historical and current market sizes and a discussion of the markets future potential. The report will help market players and new entrants make informed decisions about the production and exports of goods and services.

Report Includes:

- 41 data tables and 22 additional tables
- Description of segments and dynamics of the cell harvesting market
- Analyses of global market trends with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Characterization and quantification of market potential for cell harvesting by type of harvesting, procedure, end user, component/equipment and region
- A brief study and intact information about the market development, and future trends that can be useful for the organizations involved in
- Elaboration on the influence of government regulations, current technology, and the economic factors that will shape the future marketplace
- Key patents analysis and new product developments in cell harvesting market
- Detailed profiles of major companies of the industry, including Becton, Dickinson and Co., Corning, Inc., Fluidigm Corp., General Electric Co., Perkinelmer, Inc., and Thermo Fisher Scientific, Inc."
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analysts Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Key Market Trends
Increased Healthcare Spending to Promote the Growth of the Market
Manual Cell Harvesting Will Continue to Account for a Significant Share of the Market
North America Will Continue to Account for a Significant Share of the Market
Emphasis on Innovations in 3D Cell Culture Technology
Key Recommendations
Shifting Focus toward Small and Medium-Sized Enterprises (SMEs)
Increased Number of Partnerships and Collaborations Driving Market Growth
Emphasis on Emerging Economies
Bone Marrow is the Major Source of Stem Cells Used in Harvesting Procedures
Regulations
Cell Culture Market Overview
Factors Driving Market Growth
Factors Restraining Market Growth
Chapter 4 Market Breakdown by Type of Harvesting
Automated Cell Harvesting
Manual Cell Harvesting
Chapter 5 Market Breakdown by End User
Research Institutes
Biotechnology and Biopharmaceutical Companies
Hospitals and Clinics
Chapter 6 Market Breakdown by Application
Bone Marrow
Adipose Tissue
Peripheral Blood
Umbilical Cord
Chapter 7 Market Breakdown by Component/Equipment
Assays and Kits
Reagents and Consumables
Cell Collection and Separation Equipment
Storage and Transportation
Refrigerators
Freezers
Cryogenic Storage
Chapter 8 Market Breakdown by Region
North America
The U.S.
Canada
Europe
United Kingdom
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Middle East and Africa
Latin America
Chapter 9 New Developments and Patent Review
New Developments
ADS Biotec launched Hanabi P-1000 In Situ Harvester
Avita Medical
Corning
Vertex/CRISPR Therapeutics
General Electric Co.
Patent Analysis
Chapter 10 Analysis of Market Opportunities
Stem Cell Therapies in Clinical Trials and Pipelines
Emerging Economies
Key Supplier and Manufacturer Positioning and Strategies
Thermo Fisher Scientific, Inc.
Merck KGaA
General Electric Co.
Corning, Inc.
Terumo Corp.
Recent Activities in the Cell Harvesting Market
Collaborations and Partnerships
Geographic Expansion
Chapter 11 Company Profiles
3D BIOTEK LLC
ACELITY LP, INC.
ADS BIOTEC, INC.
AMERICAN CRYOSTEM CORP.
ANGLE PLC
ARGOS TECHNOLOGIES, INC.
ARTHREX, INC.
AVITA MEDICAL LTD.
BECTON, DICKINSON AND CO.
BIOTIUM, INC.
CESCA THERAPEUTICS, INC.
CONNECTORATE AG
CORNING, INC.
COX SCIENTIFIC LTD.
CREATIVE BIOLABS, INC.
CRISPR THERAPEUTICS AG
CRYO-CELL INTERNATIONAL, INC.
CTIBIOTECH
EMCYTE CORP.
FLUIDIGM CORP.
GENERAL ELECTRIC CO.
INSPHERO AG
MAGENTA THERAPEUTICS, INC.
MATRICEL GMBH
MEDTRONIC PLC
MERCK KGAA
MICROTISSUES, INC.
MILLENNIUM MEDICAL TECHNOLOGIES, INC.
NOVIOCELL BV
ONCTERNAL THERAPEUTICS, INC.
PERKINELMER, INC.
PFIZER, INC.
PROMOCELL GMBH
RANFAC CORP.
REGENMED SYSTEMS, INC.
ROYAL BIOLOGICS LLC
SARTORIUS AG
SCINOMIX, INC.
STEMCELL TECHNOLOGIES, INC.
SYNTHECON, INC.
TERUMO CORP.
THERMO FISHER SCIENTIFIC, INC.
THOMAS SCIENTIFIC LLC
THOMSON INSTRUMENT CO.
TOMTEC, INC.
TREVIGEN, INC.
VITA 34 AG

List of Table

List of Tables
Summary Table : Global Market for Cell Harvesting, by Component/Equipment, Through 2023
Table 1 : Examples of Industry Regulations Worldwide
Table 2 : Cost of Stem Cell Therapies, 2017
Table 3 : Global Market for Cell Harvesting, by Type, Through 2023
Table 4 : Global Market for Automated Cell Harvesting, by Region, Through 2023
Table 5 : Global Market for Manual Cell Harvesting, by Region, Through 2023
Table 6 : Global Market for Cell Harvesting, by End User, Through 2023
Table 7 : Global Market for Cell Harvesting in Research Institutes, by Region, Through 2023
Table 8 : Research Institutes in the Cell Harvesting Market
Table 9 : Global Market for Cell Harvesting in Biotechnology and Biopharmaceutical Companies, by Region, Through 2023
Table 10 : Global Market for Cell Harvesting in Hospitals and Clinics, by Region, Through 2023
Table 11 : Hospitals and Clinics in the Cell Harvesting Market
Table 12 : Global Market for Cell Harvesting, by Procedure, Through 2023
Table 13 : Global Market for Bone Marrow Cell Harvesting Procedures, by Region, Through 2023
Table 14 : Types of Bone Marrow Transplants
Table 15 : Global Market for Adipose Tissue Cell Harvesting Procedures, by Region, Through 2023
Table 16 : Global Market for Peripheral Blood Cell Harvesting Procedures, by Region, Through 2023
Table 17 : Examples of Growth Factors Secreted, by Platelets
Table 18 : Global Market for Umbilical Cord Cell Harvesting Procedures, by Region, Through 2023
Table 19 : Global Market for Cell Harvesting, by Component/Equipment, Through 2023
Table 20 : Global Market for Cell Harvesting in Assays and Kits, by Region, Through 2023
Table 21 : Selected Assays and Kits Offered, by Market Players
Table 22 : Global Market for Cell Harvesting in Reagents and Consumables, by Region, Through 2023
Table 23 : Global Market for Cell Harvesting in Cell Collection and Separation Equipment, by Region, Through 2023
Table 24 : Global Market for Cell Harvesting in Storage and Transportation, by Region, Through 2023
Table 25 : Comparison of Ultra-Low Temperature Storage Methods for Cell Lines
Table 26 : Global Market for Cell Harvesting, by Region, Through 2023
Table 27 : North American Market for Cell Harvesting, by Country, Through 2023
Table 28 : North American Market for Cell Harvesting, by Type, Through 2023
Table 29 : North American Market for Cell Harvesting, by End User, Through 2023
Table 30 : North American Market for Cell Harvesting, by Procedure, Through 2023
Table 31 : North American Market for Cell Harvesting, by Component/Equipment, Through 2023
Table 32 : North America Diabetes Statistics, 2015
Table 33 : U.S. State Initiatives for Stem Cell Research
Table 34 : Institutes Conducting Research on Stem Cells
Table 35 : European Market for Cell Harvesting, by Country, Through 2023
Table 36 : European Market for Cell Harvesting, by Type, Through 2023
Table 37 : European Market for Cell Harvesting, by End User, Through 2023
Table 38 : European Market for Cell Harvesting, by Procedure, Through 2023
Table 39 : European Market for Cell Harvesting, by Component/Equipment, Through 2023
Table 40 : Spain Diabetes Statistics, 2017
Table 41 : Colorectal Cancer Mortality Rates in European Countries, 2011-2016
Table 42 : Asia-Pacific Market for Cell Harvesting, by Country, Through 2023
Table 43 : Asia-Pacific Market for Cell Harvesting, by Type, Through 2023
Table 44 : Asia-Pacific Market for Cell Harvesting, by End User, Through 2023
Table 45 : Asia-Pacific Market for Cell Harvesting, by Procedure, Through 2023
Table 46 : Asia-Pacific Market for Cell Harvesting, by Component/Equipment, Through 2023
Table 47 : Leading Types of Cancer in Hong Kong, 2005 and 2015
Table 48 : Middle Eastern and African Market for Cell Harvesting, by Type, Through 2023
Table 49 : Middle Eastern and African Market for Cell Harvesting, by End User, Through 2023
Table 50 : Middle Eastern and African Market for Cell Harvesting, by Procedure, Through 2023
Table 51 : Middle Eastern and African Market for Cell Harvesting, by Component/Equipment, Through 2023
Table 52 : Latin American Market for Cell Harvesting, by Type, Through 2023
Table 53 : Latin American Market for Cell Harvesting, by End User, Through 2023
Table 54 : Latin American Market for Cell Harvesting, by Procedure, Through 2023
Table 55 : Latin American Market for Cell Harvesting, by Component/Equipment, Through 2023
Table 56 : Main Government Funding Agencies for Regenerative Medicine in Brazil
Table 57 : Number of Patents and Patent Applications Related to Cell Harvesting, by Category and Region/Country, January 2016 Through December 2018
Table 58 : Number of Patents and Patent Applications Related to Cell Harvesting, by Key Players/Assignees, January 2016, Through July 2018
Table 59 : Number of Patents and Patent Applications Related to Cell Harvesting, by Assignee, January 2016, Through July 2018
Table 60 : Descriptions of Patents and Patent Applications Related to Cell Harvesting, January 2016 Through July 2018
Table 61 : Monoclonal Antibodies
Table 62 : Overview of the Leading Competition, 2017-2018

List of Chart

List of Figures
Summary Figure : Global Market for Cell Harvesting, by Component/Equipment, 2017-2023
Figure 1 : Number of People Suffering from Dementia Worldwide, 2018-2030
Figure 2 : Most Commonly Reported Cancer Cases, 2018
Figure 3 : Global Fatalities Due to Different Diseases, 2016
Figure 4 : Flow Chart of Automated Cell Harvest Process
Figure 5 : Harvesting Cells From 3D Culture
Figure 6 : Healthcare Expenditures in North American Countries, 2016
Figure 7 : Colorectal Cancer Incidence and Deaths Per 100,000 Persons in the U.S., 2012-2015
Figure 8 : Share of Canadian Healthcare Investments, by Organization, 2015
Figure 9 : Percentage Share of Healthcare Expenditures, by Major Economies of the European Union, 2015
Figure 10 : Percentage Share of Total Contribution from EU Health Programs, by Country, 2007-2013
Figure 11 : Percentage Shares of EU Contribution to Stem Cell Projects, by Country, 2007-2013
Figure 12 : Estimated Prevalence of Diabetes, by Age (2079 Years) and Sex, 2015
Figure 13 : Mortality Rates in Men and Women in the U.K., by Disease Type, 2015
Figure 14 : Cancer Prevalence in Germany, by Type, 2014-2016
Figure 15 : Share of Pharmaceutical Products Developed in France, by Type, 2015
Figure 16 : Colorectal Cancer Incidence Rates in Italy, 2015 and 2016
Figure 17 : Number of Colorectal Cancer Patients in Spain, 2011-2016
Figure 18 : Health Expenditure per Capita, by Latin American Countries, 2014-2015
Figure 19 : Thermo Fisher Scientific: Revenue Share, by Complementary Segment, 2017
Figure 20 : Thermo Fisher Scientific: Revenue Share, by Region, 2017
Figure 21 : Merck: Revenue Share, by Complementary Segment, 2017
Figure 22 : Merck: Revenue Share, by Region, 2017
Figure 23 : General Electric Co.: Revenue Share, by Segment, 2017
Figure 24 : General Electric Co.: Revenue Share, by Region/Country, 2017
Figure 25 : Corning: Revenue Share, by Complementary Segment, 2017
Figure 26 : Corning: Revenue Share, by Region, 2017
Figure 27 : Terumo Corp.: Revenue Share, by Complementary Segment, 2017
Figure 28 : Terumo Corp.: Revenue Share, by Region/Country, 2017

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *